Presentation is loading. Please wait.

Presentation is loading. Please wait.

Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation  Don Hayes, MD, MS, Sylvester M. Black,

Published byTeona Ionescu Modified over 5 years ago

Similar presentations

Presentation on theme: "Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation  Don Hayes, MD, MS, Sylvester M. Black,"— Presentation transcript:

1 Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation  Don Hayes, MD, MS, Sylvester M. Black, MD, PhD, Joseph D. Tobias, MD, Stephen Kirkby, MD, Heidi M. Mansour, PhD, Bryan A. Whitson, MD, PhD  The Annals of Thoracic Surgery  Volume 101, Issue 1, Pages (January 2016) DOI: /j.athoracsur Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Patient inclusion and exclusion criteria for patients with idiopathic pulmonary fibrosis (IPF) and subsequent univariate analysis, Kaplan-Meier survival curve, multivariate Cox analysis, and propensity score matching. (PH = pulmonary hypertension.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Kaplan-Meier survival functions comparing pulmonary hypertension (blue line) and no pulmonary hypertension (red line) in patients with idiopathic pulmonary fibrosis using mean pulmonary artery pressure 25 mm Hg or greater as the threshold (n = 6,126; log rank test χ2 [df = 1] 40.44, p < 0.001). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Kaplan-Meier survival functions comparing pulmonary hypertension (blue line) and no pulmonary hypertension (red line) in patients with idiopathic pulmonary fibrosis using mean pulmonary artery pressure 35 mm Hg or greater as the threshold (n = 6,126; log rank test χ2 [df = 1] 60.62, p < 0.001). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation  Don Hayes, MD, MS, Sylvester M. Black,"

Similar presentations

Survival After Single Versus Bilateral Lung Transplantation for High-Risk Patients With Pulmonary Fibrosis  Eric S. Weiss, MD, MPH, Jeremiah G. Allen,

Survival After Single Versus Bilateral Lung Transplantation for High-Risk Patients With Pulmonary Fibrosis  Eric S. Weiss, MD, MPH, Jeremiah G. Allen,
Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.
Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,
Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis  Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,

Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis  Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,
Mauer Biscotti, MD, Whitney D

Mauer Biscotti, MD, Whitney D
Benny Weksler, MD, Jennifer L. Sullivan, MD 

Benny Weksler, MD, Jennifer L. Sullivan, MD 
Niv Ad, MD, Linda Henry, PhD, RN, Deborah J. Shuman, BS, Sari D

Niv Ad, MD, Linda Henry, PhD, RN, Deborah J. Shuman, BS, Sari D
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Chun Chieh Lin, PhD, MBA, Matthew P

Chun Chieh Lin, PhD, MBA, Matthew P
Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation  Don Hayes, MD, MS, Stephen Kirkby,

Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation  Don Hayes, MD, MS, Stephen Kirkby,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery  Farkas B. Vánky, MD, PhD, Erik.
Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis  Takekazu Iwata, MD, PhD, Shigetoshi Yoshida,

Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis  Takekazu Iwata, MD, PhD, Shigetoshi Yoshida,
ABO-Identical Blood Group Matching Has No Survival Benefit for AB Heart Transplant Recipients  Henrik Bergenfeldt, MD, Peter Höglund, MD, PhD, Bodil Andersson,

ABO-Identical Blood Group Matching Has No Survival Benefit for AB Heart Transplant Recipients  Henrik Bergenfeldt, MD, Peter Höglund, MD, PhD, Bodil Andersson,
Comparing Long-Term Survival Between Patients Undergoing Off-Pump and On-Pump Coronary Artery Bypass Graft Operations  Giovanni Filardo, PhD, MPH, Paul.

Comparing Long-Term Survival Between Patients Undergoing Off-Pump and On-Pump Coronary Artery Bypass Graft Operations  Giovanni Filardo, PhD, MPH, Paul.
Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Similar presentations

Ads by Google